AU7531094A - Protracted glp-1 - Google Patents

Protracted glp-1

Info

Publication number
AU7531094A
AU7531094A AU75310/94A AU7531094A AU7531094A AU 7531094 A AU7531094 A AU 7531094A AU 75310/94 A AU75310/94 A AU 75310/94A AU 7531094 A AU7531094 A AU 7531094A AU 7531094 A AU7531094 A AU 7531094A
Authority
AU
Australia
Prior art keywords
protracted glp
protracted
glp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75310/94A
Inventor
Hanne Agerbaek
Per Balschmidt
Klavs Holger Jorgensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK95593A external-priority patent/DK95593D0/en
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU7531094A publication Critical patent/AU7531094A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU75310/94A 1993-08-24 1994-08-23 Protracted glp-1 Abandoned AU7531094A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DK955/93 1993-08-24
DK95593A DK95593D0 (en) 1993-08-24 1993-08-24 PREPARATION
US12207793A 1993-09-15 1993-09-15
US122077 1993-09-15
PCT/DK1994/000317 WO1995005848A1 (en) 1993-08-24 1994-08-23 Protracted glp-1

Publications (1)

Publication Number Publication Date
AU7531094A true AU7531094A (en) 1995-03-21

Family

ID=26064965

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75310/94A Abandoned AU7531094A (en) 1993-08-24 1994-08-23 Protracted glp-1

Country Status (2)

Country Link
AU (1) AU7531094A (en)
WO (1) WO1995005848A1 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849708B1 (en) 1986-05-05 2005-02-01 The General Hospital Corporation Insulinotropic hormone and uses thereof
US5614492A (en) * 1986-05-05 1997-03-25 The General Hospital Corporation Insulinotropic hormone GLP-1 (7-36) and uses thereof
US7138486B2 (en) 1986-05-05 2006-11-21 The General Hospital Corporation Insulinotropic hormone derivatives and uses thereof
US6284727B1 (en) 1993-04-07 2001-09-04 Scios, Inc. Prolonged delivery of peptides
US5705483A (en) 1993-12-09 1998-01-06 Eli Lilly And Company Glucagon-like insulinotropic peptides, compositions and methods
US6277819B1 (en) 1996-08-30 2001-08-21 Eli Lilly And Company Use of GLP-1 or analogs in treatment of myocardial infarction
UA65549C2 (en) 1996-11-05 2004-04-15 Елі Ліллі Енд Компані Use of glucagon-like peptides such as glp-1, glp-1 analog, or glp-1 derivative in methods and compositions for reducing body weight
US5981488A (en) * 1997-03-31 1999-11-09 Eli Lillly And Company Glucagon-like peptide-1 analogs
US6380357B2 (en) 1997-12-16 2002-04-30 Eli Lilly And Company Glucagon-like peptide-1 crystals
US6528486B1 (en) 1999-07-12 2003-03-04 Zealand Pharma A/S Peptide agonists of GLP-1 activity
CA2430934C (en) 2000-12-01 2011-06-21 Takeda Chemical Industries, Ltd. A method of producing sustained-release preparations of a bioactive substance using high-pressure gas
WO2002048192A2 (en) 2000-12-13 2002-06-20 Eli Lilly And Company Amidated glucagon-like peptide-1
US20030119734A1 (en) 2001-06-28 2003-06-26 Flink James M. Stable formulation of modified GLP-1
CA2471363C (en) 2001-12-21 2014-02-11 Human Genome Sciences, Inc. Albumin fusion proteins
BR0307727A (en) 2002-02-20 2005-01-25 Lilly Co Eli Fomulation
PT3300721T (en) * 2003-11-20 2019-06-06 Novo Nordisk As Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
US20060286129A1 (en) 2003-12-19 2006-12-21 Emisphere Technologies, Inc. Oral GLP-1 formulations
ES2458991T3 (en) 2004-11-12 2014-05-07 Novo Nordisk A/S Stable insulinotropic peptide formulations
EP2111871A1 (en) * 2008-04-26 2009-10-28 Sandoz AG Stabilised fluid formula
GB201001333D0 (en) 2010-01-27 2010-03-17 Imp Innovations Ltd Novel compounds and their effects on feeding behaviour
CA2797133C (en) 2010-04-27 2019-08-06 Zealand Pharma A/S Peptide conjugates of glp-1 receptor agonists and gastrin and their use
US20140004198A1 (en) * 2011-01-19 2014-01-02 Novo Nordisk A/S Glp-1 particles and compositions
US20140045754A1 (en) * 2011-01-19 2014-02-13 Joern Drustrup Glp-1 compositions
GB201101459D0 (en) 2011-01-27 2011-03-16 Imp Innovations Ltd Novel compounds and thier effects on fedding behaviour
WO2013004983A1 (en) 2011-07-04 2013-01-10 Imperial Innovations Limited Novel compounds and their effects on feeding behaviour
EA028951B9 (en) 2011-11-03 2018-05-31 Зилэнд Фарма А/С Peptide conjugates of gastrin and glucagon-like peptide 1 receptor agonist
EP2873422A4 (en) 2012-07-10 2015-12-30 Takeda Pharmaceutical Pharmaceutical preparation for injection
AR091866A1 (en) 2012-07-23 2015-03-04 Zealand Pharma As GLUCAGON ANALOGS
TWI608013B (en) 2012-09-17 2017-12-11 西蘭製藥公司 Glucagon analogues
ES2688708T3 (en) 2013-10-17 2018-11-06 Zealand Pharma A/S Acylated glucagon analogs
US9988429B2 (en) 2013-10-17 2018-06-05 Zealand Pharma A/S Glucagon analogues
MX2016005556A (en) 2013-11-06 2016-07-15 Zealand Pharma As Gip-glp-1 dual agonist compounds and methods.
CN105829339B (en) 2013-11-06 2021-03-12 西兰制药公司 glucagon-GLP-1-GIP triple agonist compounds
JP6898231B6 (en) 2014-10-29 2021-07-28 ジーランド ファーマ アクティーゼルスカブ GIP agonist compounds and methods
AU2016247499B2 (en) 2015-04-16 2020-09-03 Zealand Pharma A/S Acylated glucagon analogue
KR102502040B1 (en) 2016-12-09 2023-02-24 질랜드 파마 에이/에스 Acylated GLP-1/GLP-2 dual agonists
WO2019038412A1 (en) 2017-08-24 2019-02-28 Novo Nordisk A/S Glp-1 compositions and uses thereof
AU2021207313A1 (en) 2020-02-18 2022-07-28 Novo Nordisk A/S Pharmaceutical formulations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04504246A (en) * 1989-03-20 1992-07-30 ザ・ジェネラル・ホスピタル・コーポレーション insulin stimulating hormone

Also Published As

Publication number Publication date
WO1995005848A1 (en) 1995-03-02

Similar Documents

Publication Publication Date Title
AU7531094A (en) Protracted glp-1
AU7583794A (en) 1-amino-ethylindole-derivatives
AU6001594A (en) Imidazoazines
AU6710294A (en) Tetrahydro-beta-carbolines
AU6984494A (en) Antitussive
AU6705294A (en) Tetrahydro-pyrido-indole
AU7220794A (en) Detergent-package combination
AU1198795A (en) Boat
AU8057694A (en) Marine structure
AU675824B2 (en) Improved antenna structure
AU5798394A (en) Thiadiazinones
AU6259294A (en) Life-savingfloat
AU1274295A (en) Heteroarylpyrroles
AU6389494A (en) Tv-projector
AU8104694A (en) Bagbottle
AU6971594A (en) Cyclobutylazoles
AU6427194A (en) Aza-androstane-17beta -carboxamides
AU3696093A (en) Aquamate
AU5780894A (en) Crankhead
AU7285994A (en) Suncap
AU6726594A (en) Tee-box
AU5830994A (en) Zusammenklappbares baukastensystem
AU4833093A (en) Construction set
AU674745B2 (en) Eco-brick
AU7000494A (en) Aralkylaminoquinazolines